BG
INFI

BlackRock Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Group’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-24,775
Closed -$39K – 3008
2016
Q3 		$39K Sell
24,775
-1,336
-5% -$2.05K ﹤0.01% 2938
2016
Q2 		$35K Sell
26,111
-448
-2% -$2.1K ﹤0.01% 2960
2016
Q1 		$140K Sell
26,559
-14,300
-35% -$87.5K ﹤0.01% 2669
2015
Q4 		$320K Sell
40,859
-601
-1% -$5.17K ﹤0.01% 2369
2015
Q3 		$350K Buy
41,460
+1,369
+3% +$12.6K ﹤0.01% 2339
2015
Q2 		$439K Buy
40,091
+3,727
+10% +$47.8K ﹤0.01% 2314
2015
Q1 		$509K Sell
36,364
-2,362
-6% -$36.1K ﹤0.01% 2193
2014
Q4 		$654K Buy
38,726
+28,400
+275% +$414K ﹤0.01% 2124
2014
Q3 		$138K Sell
10,326
-298
-3% -$3.55K ﹤0.01% 2535
2014
Q2 		$135K Sell
10,624
-15,428
-59% -$161K ﹤0.01% 2545
2014
Q1 		$310K Buy
26,052
+6,002
+30% +$80.5K ﹤0.01% 2363
2013
Q4 		$277K Sell
20,050
-283,284
-93% -$4M ﹤0.01% 2353
2013
Q3 		$5.29M Buy
303,334
+1,289
+0.4% +$24.7K ﹤0.01% 1052
2013
Q2 		$4.89M Buy
+302,045
New +$9.35M ﹤0.01% 1004

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Group's INFI Position: Q4 2016 in Review

BlackRock Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 24,775 shares — an estimated $39K sold.

BlackRock Group first reported a position in INFI in Q2 2013 and held it in 14 quarters. The position peaked at $5.29M in Q3 2013. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • BlackRock Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • BlackRock Group sold 24,775 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $39K.
  • BlackRock Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • BlackRock Group's Infinity Pharmaceuticals, Inc. position peaked at $5.29M in Q3 2013.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.